Development and Scale-Up of a Direct Asymmetric Reductive Amination with Ammonia

Stereoselective Amine Synthesis Mediated by a Zirconocene Hydride to Accelerate a Drug Discovery Program

Chiral amine synthesis remains a significant challenge in accelerating the design cycle of drug discovery programs. A zirconium hydride, due to its high oxophilicity and lower reactivity, gave highly chemo- and stereoselective reductions of sulfinyl ketimines. The development of this zirconocene-mediated reduction helped to accelerate our drug discovery efforts and is applicable to several motifs commonly used in medicinal chemistry. Computational investigation supported a cyclic half-chair transition state to rationalize the high selectivity in benzyl systems.

Enantioselective Transformations in the Synthesis of Therapeutic Agents

The proportion of approved chiral drugs and drug candidates under medical studies has surged dramatically over the past two decades. As a consequence, the efficient synthesis of enantiopure pharmaceuticals or their synthetic intermediates poses a profound challenge to medicinal and process chemists. The significant advancement in asymmetric catalysis has provided an effective and reliable solution to this challenge. The successful application of transition metal catalysis, organocatalysis, and biocatalysis to the medicinal and pharmaceutical industries has promoted drug discovery by efficient and precise preparation of enantio-enriched therapeutic agents, and facilitated the industrial production of active pharmaceutical ingredient in an economic and environmentally friendly fashion. The present review summarizes the most recent applications (2008-2022) of asymmetric catalysis in the pharmaceutical industry ranging from process scales to pilot and industrial levels. It also showcases the latest achievements and trends in the asymmetric synthesis of therapeutic agents with state of the art technologies of asymmetric catalysis.

Hexaazatrinaphthalene-Based Covalent Triazine Framework-Supported Rhodium(III) Complex: A Recyclable Heterogeneous Catalyst for the Reductive Amination of Ketones to Primary Amines

The development of efficient and recyclable heterogeneous catalysts is an important topic. Herein, a rhodium(III) complex Cp*Rh@HATN-CTF was synthesized by the coordinative immobilization of [Cp*RhCl₂]₂ on a hexaazatrinaphthalene-based covalent triazine framework. In the presence of Cp*Rh@HATN-CTF (1 mo l% Rh), a series of primary amines could be obtained via the reductive amination of ketones in high yields. Moreover, catalytic activity of Cp*Rh@HATN-CTF is well maintained during six runs. The present catalytic system was also applied for the large scale preparation of a biologically active compound. It would facilitate the development of CTF-supported transition metal catalysts for sustainable chemistry.

The Direct Conversion of Esters to Ketones Enabled by a Traceless Activating Group

We report here the design and development of a method for the single-step conversion of esters to ketones with simple reagents. The selective transformation of esters to ketones, rather than tertiary alcohols, is made possible by the use of a transient sulfinate group on the nucleophile that activates the adjacent carbon toward deprotonation to form a carbanion that adds to the ester, followed by a second deprotonation to prevent further addition. The resulting dianion undergoes spontaneous fragmentation of the SO₂ group upon quenching with water to reveal the ketone product.

A Brief Review: Advancement in the Synthesis of Amine through the Leuckart Reaction

This review presents a summary of reactions that take place during the “Leuckart-type reaction”. The significance of, as well as recent advancements in, the synthesis of amines through simple and inexpensive methods using readily available raw materials is discussed. This review includes all catalytic and noncatalytic reactions that involve the Leuckart method. Recent studies have shown that at least a quarter of C–N bond-forming reactions in the pharmaceutical industry are occur with the support of reductive amination. Recently, experimental conditions have achieved excellent yields. The “Leuckart-type reaction” is technically associated with Eschweiler–Clarke methylation. Compounds are grouped in accordance with the precept of action. This includes drugs affecting the central nervous system, cardiovascular system and gastrointestinal tract; anticancer drugs, antibiotics, antiviral and antifungal drugs; drugs affecting anxiety; convulsant, biotic, and HIV drugs; and antidiabetic drugs. Therefore, this review supports the development of the Leuckart-type preparation of nitrogenous compounds, as well as their advancement in other areas of human development.

Catalytic utilization of converter gas – an industrial waste for the synthesis of pharmaceuticals

From waste to value. An efficient and convenient ruthenium-catalyzed reduction of aromatic nitro compounds using converter gas as a reducing agent to produce valuable pharmaceuticals has been developed.

Branched Tertiary Amines from Aldehydes and α-Olefins by Combined Multiphase Tandem Reactions

This study presents the transformation of olefins to branched amines by combining a hydroformylation/aldol condensation tandem reaction with the reductive amination in a combined multiphase system that can be recycled 9 times. The products are branched amines that are precursors for surfactants. Since the multiphase hydrofomylation/aldol condensation system has already been studied, the first step was to develop the partial hydrogenation of unsaturated aldehydes together with a subsequent reductive amination. The rhodium/phosphine catalyst is immobilized in a polar polyethylene phase which separates from the product phase after the reaction. Reaction and catalyst recycling are demonstrated by the conversion of the C₁₄ -aldehyde 2-pentylnonenal with the dimethylamine surrogate dimethylammonium dimethylcarbamate to the corresponding tertiary amine with yields up to 88 % and an average rhodium leaching of less than 0.1 % per recycling run. Furthermore, the positive influence of a Bronsted acid and carbon monoxide on the selectivity are discussed. Finally, the two PEG based systems have been merged in one recycling approach, by using the product phase of the hydroformylation aldol condensation reaction for the reductive amination reaction. The yields are stable during a nine recycling runs and the leaching low with 0.09 % over the two recycling stages.

An Iridium Catalytic System Compatible with Inorganic and Organic Nitrogen Sources for Dual Asymmetric Reductive Amination Reactions

Asymmetric reductive amination (ARA) is one of the most promising methods for the synthesis of chiral amines. Herein we report our efforts on merging two ARA reactions into a single-step transformation. Catalyzed by a complex formed from iridium and a steric hindered phosphoramidite, readily available and inexpensive aromatic ketones initially undergo the first ARA with ammonium acetate to afford primary amines, which serve as the amine sources for the second ARA, and finally provide the enantiopure C₂ -symmetric secondary amine products. The developed process competently enables the successive coupling of inorganic and organic nitrogen sources with ketones in the same reaction system. The Brønsted acid additive plays multiple roles in this procedure: it accelerates the formation of imine intermediates, minimizes the inhibitory effect of N-containing species on the iridium catalyst, and reduces the primary amine side products.

Recent advances on transition-metal-catalysed asymmetric reductive amination

This review focuses on the recent progress of homogeneous transition-metal-catalysed asymmetric reductive amination of ketones with diverse nitrogen sources.